{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:25:45Z","timestamp":1773275145700,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2001,6,1]]},"DOI":"10.1038\/sj.gt.3301467","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T18:58:42Z","timestamp":1032375522000},"page":"891-895","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["T cells engrafted with a recombinant anti-CD30 receptor target autologous CD30+ cutaneous lymphoma cells"],"prefix":"10.1038","volume":"8","author":[{"given":"A","family":"Hombach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J M","family":"Muche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Gerken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Gellrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Heuser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Pohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Sterry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Abken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2001,6,22]]},"reference":[{"key":"BF3301467_CR1","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1073\/pnas.90.2.720","volume":"90","author":"Z Eshhar","year":"1993","unstructured":"Eshhar Z, Waks T, Gross G, Schindler DG . Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors Proc Natl Acad Sci USA 1993 90: 720\u2013724","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301467_CR2","first-page":"3369","volume":"55","author":"P Hwu","year":"1995","unstructured":"Hwu P et al. In vivo antitumor activity of T cells redirected with chimeric antibody\/T cell receptor genes Cancer Res 1995 55: 3369\u20133373","journal-title":"Cancer Res"},{"key":"BF3301467_CR3","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.4049\/jimmunol.159.11.5509","volume":"159","author":"U Altenschmidt","year":"1997","unstructured":"Altenschmidt U, Klundt E, Groner B . Adoptive transfer of in vitro-targeted, activated T lymphocytes results in total tumor regression J Immunol 1997 159: 5509\u20135515","journal-title":"J Immunol"},{"key":"BF3301467_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0167-5699(97)01191-2","volume":"19","author":"H Abken","year":"1998","unstructured":"Abken H, Hombach A, Reinhold U, Ferrone S . Can combined T cell- and antibody-based immunotherapy outsmart tumor cells? Immunol Today 1998 19: 2\u20135","journal-title":"Immunol Today"},{"key":"BF3301467_CR5","first-page":"685","volume":"60","author":"G Willimsky","year":"2000","unstructured":"Willimsky G, Blankenstein T . Interleukin-7\/B7.1-encoding adenoviruses induce rejection of transplanted but not nontransplanted tumors Cancer Res 2000 60: 685\u2013692","journal-title":"Cancer Res"},{"key":"BF3301467_CR6","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/9525","volume":"5","author":"PP Lee","year":"1999","unstructured":"Lee PP et al. Characterization of circulating T cells specific for tumor associated antigens in melanoma patients Nat Med 1999 5: 677\u2013685","journal-title":"Nat Med"},{"key":"BF3301467_CR7","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.4049\/jimmunol.163.11.6292","volume":"163","author":"KH Lee","year":"1999","unstructured":"Lee KH et al. Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but does not lead to tumor regression J Immunol 1999 163: 6292\u20136300","journal-title":"J Immunol"},{"key":"BF3301467_CR8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0092-8674(92)90180-K","volume":"68","author":"H D\u00fcrkop","year":"1992","unstructured":"D\u00fcrkop H et al. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease Cell 1992 68: 421\u2013427","journal-title":"Cell"},{"key":"BF3301467_CR9","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.4049\/jimmunol.151.5.2380","volume":"151","author":"TM Ellis","year":"1993","unstructured":"Ellis TM et al. CD30 is a signal transducing molecule that defines a subset of human activated CD45RO+ T cells J Immunol 1993 151: 2380\u20132389","journal-title":"J Immunol"},{"key":"BF3301467_CR10","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/S0092-8674(00)81031-4","volume":"84","author":"R Amakawa","year":"1996","unstructured":"Amakawa R et al. Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice Cell 1996 84: 551\u2013562","journal-title":"Cell"},{"key":"BF3301467_CR11","first-page":"1116","volume":"58","author":"A Hombach","year":"1998","unstructured":"Hombach A et al. A chimeric T cell receptor recognizing the CD30 antigen converts cytotoxic T cells to specificity for Hodgkin and Reed Stemberg cells Cancer Res 1998 58: 1116\u20131119","journal-title":"Cancer Res"},{"key":"BF3301467_CR12","first-page":"354","volume":"90","author":"R Willemze","year":"1997","unstructured":"Willemze R et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer Blood 1997 90: 354\u2013371","journal-title":"Blood"},{"key":"BF3301467_CR13","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/(SICI)1097-0215(20000301)85:5<618::AID-IJC4>3.0.CO;2-Z","volume":"85","author":"U Trefzer","year":"2000","unstructured":"Trefzer U et al. Hybrid cell vaccination for cancer immune therapy: first clinical trial with metastatic melanoma Int J Cancer 2000 85: 618\u2013626","journal-title":"Int J Cancer"},{"key":"BF3301467_CR14","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/sj.gt.3300813","volume":"6","author":"A Hombach","year":"1999","unstructured":"Hombach A et al. A chimeric receptor that selectively targets membrane-bound carcinoembryonic antigen (mCEA) in the presence of soluble CEA Gene Therapy 1999 6: 300\u2013304","journal-title":"Gene Therapy"},{"key":"BF3301467_CR15","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/sj.gt.3301195","volume":"7","author":"A Hombach","year":"2000","unstructured":"Hombach A et al. T cell activation by recombinant Fc\u03b5RI \u03b3-chain immune receptors: an extracellular spacer domain impairs antigen dependent T cell activation but not antigen-recognition Gene Therapy 2000 7: 1067\u20131075","journal-title":"Gene Therapy"},{"key":"BF3301467_CR16","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/sj.gt.3300696","volume":"5","author":"ME Weijtens","year":"1998","unstructured":"Weijtens ME, Willemsen RA, Hart EH, Bolhuis RL . A retroviral vector system \u2018STITCH\u2019 in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes Gene Therapy 1998 5: 1195\u20131203","journal-title":"Gene Therapy"},{"key":"BF3301467_CR17","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/ijc.2910540312","volume":"54","author":"C Pohl","year":"1993","unstructured":"Pohl C et al. CD30 specific AB1-AB2-AB3 internal image antibody network: potential use as anti-idiotype vaccine against Hodgkin's lymphoma Int J Cancer 1993 54: 418\u2013425","journal-title":"Int J Cancer"},{"key":"BF3301467_CR18","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/bjc.1993.84","volume":"67","author":"A Bruynk","year":"1993","unstructured":"Bruynk A, Seemann G, Bosslet K . Charcterization of a humanized bispecific monoclonal antibody for cancer therapy Br J Cancer 1993 67: 436\u2013440","journal-title":"Br J Cancer"},{"key":"BF3301467_CR19","doi-asserted-by":"crossref","first-page":"836","DOI":"10.4049\/jimmunol.157.2.836","volume":"157","author":"ME Weijtens","year":"1996","unstructured":"Weijtens ME et al. Single chain Ig\/gamma gene-redirected human T lymphocytes produce cytokines, specifically lyse tumor cells, and recycle lytic capacity J Immunol 1996 157: 836\u2013843","journal-title":"J Immunol"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3301467.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3301467","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3301467.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,7]],"date-time":"2024-01-07T01:26:24Z","timestamp":1704590784000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3301467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6,1]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2001,6,1]]}},"alternative-id":["BF3301467"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3301467","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6,1]]},"assertion":[{"value":"21 December 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2001","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}